| Product NDC: | 0052-0105 |
| Proprietary Name: | REMERON |
| Non Proprietary Name: | MIRTAZAPINE |
| Active Ingredient(s): | 15 mg/1 & nbsp; MIRTAZAPINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0052-0105 |
| Labeler Name: | Organon Pharmaceuticals USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020415 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960614 |
| Package NDC: | 0052-0105-30 |
| Package Description: | 1 BOTTLE in 1 CARTON (0052-0105-30) > 30 TABLET, FILM COATED in 1 BOTTLE |
| NDC Code | 0052-0105-30 |
| Proprietary Name | REMERON |
| Package Description | 1 BOTTLE in 1 CARTON (0052-0105-30) > 30 TABLET, FILM COATED in 1 BOTTLE |
| Product NDC | 0052-0105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MIRTAZAPINE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19960614 |
| Marketing Category Name | NDA |
| Labeler Name | Organon Pharmaceuticals USA |
| Substance Name | MIRTAZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |